What is the role of hormone therapy in the treatment of ovarian cancer?

Updated: Aug 10, 2020
  • Author: Andrew E Green, MD; Chief Editor: Yukio Sonoda, MD  more...
  • Print

Case reports have raised the possibility of the use of hormonal therapy in the management of recurrent granulose-theca cell tumors. Responses to medroxyprogesterone acetate, gonadotropin-releasing hormone (GnRH) agonists, and megestrol (Megace) have all been reported in a small number of patients with progressive disease not responsive to chemotherapy. [114]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!